Blueberries for Gut, Brain, and Cardiometabolic Health in Prediabetes
Launched by GEORGIA STATE UNIVERSITY · Dec 11, 2024
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring the effects of freeze-dried wild blueberry powder on various health aspects in adult women who have prediabetes. The researchers want to see if this blueberry powder can improve heart and brain health, as well as the balance of bacteria in the gut. If you are a woman aged between 45 and 65, with a blood sugar level indicating prediabetes, and a body mass index (BMI) between 25 and 30, you might be eligible to participate.
During the trial, participants will take the blueberry powder and be monitored for changes in their health, such as blood sugar levels, cognitive function, and gut health. However, there are certain criteria that might exclude some women from joining, like having allergies to berries, certain medical conditions, or taking specific medications. Overall, this study aims to find out if blueberries can be a helpful addition to managing prediabetes in women.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Women aged 45-65 years old
- • Prediabetes (fasting blood glucose 100-125 mg/dL and/or HbA1c percentage between 5.7-6.4)
- • Body Mass Index between 25-30 kg/m\^2
- Exclusion Criteria:
- • Allergies to berries
- • Use of insulin, antidiabetic, antibiotics, and anti-inflammatory drugs
- • Active cancer, gastrointestinal, renal, thyroid, stage 1 \& 2 hypertension and other cardiovascular diseases, neurological diseases, or severe head injury
- • Smoking
- • Consumes greater than 2 alcoholic beverages per day
- • Consumes antioxidant, probiotic, and prebiotic supplements
- • Pregnant or Lactating
- • Actively participating in a weight loss program
- • Currently taking berry supplements or recently participated in another study taking berry supplements
About Georgia State University
Georgia State University is a leading research institution dedicated to advancing knowledge through innovative clinical trials and studies. With a strong emphasis on public health and community well-being, the university leverages its multidisciplinary expertise to conduct rigorous research aimed at addressing pressing health challenges. As a sponsor of clinical trials, Georgia State University fosters collaboration among researchers, healthcare professionals, and community partners, ensuring ethical standards and scientific integrity are upheld throughout the research process. Its commitment to translating research findings into real-world applications positions the university as a key contributor to the advancement of medical science and improved patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Atlanta, Georgia, United States
Patients applied
Trial Officials
Rafaela G Feresin, PhD
Principal Investigator
Georgia State University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported